Sign in
4

Changes in Ownership

TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-21-009646

Exec. VP Chief Legal Officer sold 65,312 shares at $12.69 ($829,103)

  • Exec. VP Chief Legal Officer acquired 52,774 shares (grant or award)
  • Exec. VP Chief Legal Officer acquired 12,538 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Stark David Matthew · Exec. VP Chief Legal Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2021-02-09 Exercise or conversion : show line 1 in the form +12,538 15,512.39 D
2021-02-09 Grant or award : show line 2 in the form +52,774 68,286.39 D
2021-02-09 Sale : show line 3 in the form −12,538 $12.69 $159,164 55,748.39 D
2021-02-09 Sale : show line 4 in the form −52,774 $12.69 $669,940 2,974.39 D
Open-market sales · 65,312 sh · avg $12.69 · $829,103

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-02-09 Exercise or conversion : show line 5 in the form Restricted Share Units −12,538 12,538 D
2021-02-09 Grant or award : show line 6 in the form Restricted Share Units +37,884 37,884 D
Loading xslF345X03/doc4.xml…